In this article for Forbes.com I shared a deeply personal experience about the decision I made to step down from a company I co-founded.
Read more →This month’s post on Tech Cocktail talks about how to take advantage of small business R&D grants from the federal government. If you qualify, this is an exceptional way to bring funds into your company without giving up equity or paying royalties.
Read more →In this guest post on Forbes.com, I talk about a recently announced scientific breakthrough from Harvard and MIT–and the impediments toward bringing it to market in successful products. The posting can be found here. Please join the discussion.
Read more →In the summer of 1978, when I was 15 years old and didn’t even have a driver’s license, I sold Cokes as a vendor at Wrigley Field. You know, the guys who run up and down the aisles yelling, “Who wants a cold Coke?” at the top […]
Read more →For this month’s post on Tech Cocktail I talk about leadership and ethics.
Read more →For my monthly blog post on Tech Cocktail I talk briefly about the four questions that must be asked at every Passover Seder and during every investor pitch.
Read more →Here is my post for this month on Tech Cocktail. The subject is a dissection of what really happens in a down round. The arithmetic is not quite as straight forward as it appears. Instead of just lowering the share price, the price is often lowered retroactively […]
Read more →Many people are fascinated by this question, and in my monthly post on Tech Cocktail, I’ve taken a crack at answering it.
Read more →Here is my latest post on Tech Cocktail about the hazards of financing your company with convertible notes (debt). Neil Kane
Read more →
I'm Neil Kane - a serial entrepreneur who specializes in commercializing complex technologies that come out of academic research labs or federal laboratories.